WuXi AppTec
WuXi AppTec is a global contract research, development, and manufacturing organization that provides R&D, testing, and manufacturing services across small-molecule drugs, biologics, cell and gene therapies, and medical devices to pharmaceutical, biotech, and medical device companies. It operates an integrated platform spanning discovery, preclinical development, clinical trial support, and commercial-scale manufacturing, generating revenue through fee-for-service and long-term outsourcing contracts. The company enables clients to accelerate drug discovery and development while reducing fixed infrastructure costs.
- Revenue
- $1B+
- Employees
- 5,001+
- Founded
- 2000
- Headquarters
- Shanghai, China
WuXi AppTec customers on Arbolus
Customers who reviewed WuXi AppTec
Seniority of WuXi AppTec customers
The largest group of people who reviewed WuXi AppTec holds Director roles (45%), followed by C-Suite (36%) and Manager (19%).
- Director 45%
- C-Suite 36%
- Manager 19%
Customers sample
Employer names and spend open in the full report, along with the other 46 customers.
What 49 Arbolus experts think of WuXi AppTec
Overall sentiment: Positive
NPS distribution shows 38.8% Promoters, 36.7% Passives, and 24.5% Detractors, with an NPS score of 14.3 and average NPS of 7.78. Renewal intent is mixed: 38.2% Yes, 5.9% No, and 55.9% Not Sure. Stickiness is high, with 69.4% of customers using WuXi for more than one year. Key feedback themes include unmatched scale and speed, capital efficiency, and significant concerns about geopolitical risk and IP protection.
Everything 49 customers told us about WuXi AppTec.
Employer names, spend, renewal intent and every written answer behind the numbers on this page.
Sentiment
12 Net Promoter Score, from 49 scored reviews- Promoters 18
- Passives 19
- Detractors 12
Praised
- Unmatched Scale and Speed
- Capital Efficiency for Startups
Criticised
- Geopolitical and IP Risk
- Regulatory and Geopolitical Threats
What WuXi AppTec customers say
Unmatched Scale and Speed
“I would highly recommend WuXi because their ability to turn capital into clinical data is unmatched; you are renting an entire, highly optimized drug development infrastructure that accelerates your path to IND faster than anyone else.”
Capital Efficiency for Startups
“I would recommend WuXi to a newly funded biotech startup that needs to hit aggressive clinical milestones quickly and wants to preserve cash by avoiding internal lab build-outs.”
Geopolitical and IP Risk
“The biggest gap and risk factor with WuXi is geopolitical exposure and supply chain vulnerability, especially due to US-China trade relations and concerns around IP ring-fencing.”
Renewal intent
Plan to renew 38%Plan to renew, by seniority
- 46% 13 answers
- 29% 14 answers
- 60% 5 answers
- 0% 2 answers
- 8.5/10 Average score from customers who will renew
- 7.2/10 Average score from undecided customers
- 8/10 Average score from customers not renewing
Report
For people who use WuXi AppTec
Do you use WuXi AppTec at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 49 customers of WuXi AppTec have already contributed
Takes a few minutes. Your identity stays anonymous.